听力障碍发病率及纯音平均听阈代际变化
该队列研究基于EHLS和BOSS两个研究共3651名基线无听力障碍的成人,随访5年和10年。结果显示听力障碍5年发病率为14.1%,10年累积发病率为26.0%。校正多变量后,5年发病风险随出生世代更晚而降低(RR=0.80,95%CI 0.66-0.97),纯音平均听阈变化率也随世代降低。
要点
- 听力障碍发病率随出生世代更晚而降低,校正后5年发病风险RR=0.80。
- 纯音平均听阈变化率在Greatest Generation最高(7.03 dB HL/5年),后续世代显著更低。
- Silent Generation和Baby Boom Generation风险低于Greatest Generation,部分与可改变因素变化有关。
核心结论
- 听力障碍发病风险和纯音平均听阈变化率在Silent Generation和Baby Boom Generation中低于Greatest Generation,部分与可改变因素变化有关。
- Generation X可能持续受益,未来听力障碍负担可能低于当前估计。
研究设计与样本
- 队列研究,使用EHLS(基线1993-1995年)和BOSS(基线2005-2008年)数据,各进行两次5年随访。
- 纳入3651名基线无听力障碍且有随访数据的成人,基线平均年龄53.1岁(SD 10.6),女性2255人(61.8%),非西班牙裔白人3567人(97.7%)。
主要发现
- 5年听力障碍发病率为14.1%(95%CI 13.0%-15.3%),10年累积发病率为26.0%(95%CI 24.6%-27.6%),发病率随年龄增加。
- 校正多变量后,5年发病风险随世代降低(RR=0.80,95%CI 0.66-0.97),10年风险HR=0.86(95%CI 0.73-1.01)。
- 纯音平均听阈每5年变化率:Greatest Generation(出生1901-1924)7.03 dB HL,Silent Generation(1925-1945)3.30 dB HL,Baby Boom Generation(1946-1964)3.36 dB HL,Generation X(1965-1984)2.33 dB HL,后三者均显著低于Greatest Generation。
关键数值与推荐
- 听力障碍定义为任一侧耳纯音平均听阈大于25 dB HL。
- 5年发病率关联用相对风险(RR)估计,10年累积发病率用风险比(HR)估计,纯音平均听阈10年变化用广义估计方程模型中的世代×时间交互项分析。
临床怎么用
- 临床评估听力障碍风险时应考虑出生世代因素,较晚世代风险可能更低。
- 针对可改变因素进行干预可能部分解释世代间听力障碍风险差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Age-adjusted prevalence of hearing impairment (HI) decreased across generations in the 20th century, suggesting that HI is partially preventable. It is not known whether HI incidence differs by generation. OBJECTIVES: To examine whether HI incidence and change in pure-tone average (PTA) differ by generation and identify factors underlying these differences. DESIGN, SETTING, AND PARTICIPANTS: This cohort study used data from the Epidemiology of Hearing Loss Study (EHLS) and Beaver Dam Offspring Study (BOSS), a pair of studies of adults in Beaver Dam, Wisconsin. Baseline examinations occurred from 1993 to 1995 in the EHLS and 2005 to 2008 in BOSS, with two 5-year follow-up examinations in each cohort. This longitudinal cohort study assessed 3651 participants without HI at baseline who had follow-up data. MAIN OUTCOMES AND MEASURES: The primary outcome was incident HI measured by pure-tone audiometry, defined as PTA greater than 25-dB hearing level (dB HL) in either ear. Associations of 5-year incidence were estimated by relative risks (RRs) and 10-year cumulative incidence with generation, as categorized by commonly used sociodemographic descriptors of year of birth, by hazard ratios (HRs). The 10-year change in PTA was investigated using a generation × time interaction term in generalized estimating equation models. RESULTS: Among the 3651 participants (mean [SD] age at baseline 53.1 [10.6] years; 2255 [61.8%] female; and 3567 [97.7%] non-Hispanic White), the 5-year HI incidence was 14.1% (95% CI, 13.0%-15.3%) and the 10-year cumulative incidence was 26.0% (95% CI, 24.6%-27.6%). The incidence increased with age. The risk of 5-year incident HI decreased by generation (RR, 0.80; 95% CI, 0.66-0.97) when adjusting for multiple covariates. The decreased risk was similar in the 10-year period (HR, 0.86; 95% CI, 0.73-1.01). The PTA change rate (per 5 years of follow-up) decreased by generation, with the Greatest Generation (born 1901-1924) experiencing the highest rate (7.03 dB HL). The rates were all significantly lower for the other generations (Silent Generation [born 1925-1945], 3.30 dB HL; Baby Boom Generation [born 1946-1964], 3.36 dB HL; and Generation X [born 1965-1984], 2.33 dB HL). CONCLUSIONS AND RELEVANCE: This study suggests that the risk of HI and rate of PTA change is lower for the Silent Generation and Baby Boom Generation compared with the Greatest Generation. Part of this lower risk is likely associated with changes in modifiable factors. A potential continued benefit may exist for Generation X. Combined with the reduced risk of HI for the Silent Generation and Baby Boom Generation, this finding implies that the future HI burden may be lower than current estimates suggest.
引用
- Paulsen AJ, Fischer ME, Pinto A, et al. Incidence of Hearing Impairment and Changes in Pure-Tone Average Across Generations. JAMA Otolaryngol Head Neck Surg. 2021. PMID: 33211071. doi:10.1001/jamaoto.2020.4352
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。